2024 Q1 Form 10-Q Financial Statement

#000095017024054963 Filed on May 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q1
Revenue $9.446M
YoY Change -11.09%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.632M
YoY Change -26.43%
Operating Profit $7.902M
YoY Change -7.25%
Interest Expense $40.12K
YoY Change -2.96%
% of Operating Profit 0.51%
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings $129.0M
YoY Change 1506.04%
Net Earnings / Revenue 1365.75%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 32.25M
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $789.2M
YoY Change -13.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $510.1K
YoY Change -89.19%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $788.7M
YoY Change
Total Liabilities & Shareholders Equity $789.2M
YoY Change -13.61%

Cashflow Statement

Concept 2024 Q1
OPERATING ACTIVITIES
Net Income $129.0M
YoY Change 1506.04%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $41.24M
YoY Change -77.58%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid $336.2K
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -45.97M
YoY Change -75.01%
NET CHANGE
Cash From Operating Activities 41.24M
Cash From Investing Activities
Cash From Financing Activities -45.97M
Net Change In Cash -4.721M
YoY Change
FREE CASH FLOW
Cash From Operating Activities $41.24M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001383082
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q1 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-09-30
CY2024Q1 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-11-30
CY2024Q1 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-07-31
CY2024Q1 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-07-31
CY2024Q1 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-05-31
CY2024Q1 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-06-30
CY2024Q1 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-06-30
CY2024Q1 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-05-31
CY2024Q1 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-05-31
CY2024Q1 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-05-31
CY2024Q1 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-06-30
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-09-30
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-11-30
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-07-31
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-07-31
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-03-31
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-02-29
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-02-29
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-03-31
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-03-31
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-03-31
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-06-30
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-33238
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
INVESCO DB AGRICULTURE FUND
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0778078
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
c/o Invesco Capital Management LLC
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
3500 Lacey Road
CY2024Q1 dei Entity Address Address Line3
EntityAddressAddressLine3
Suite 700
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Downers Grove
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60515
CY2024Q1 dei City Area Code
CityAreaCode
800
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
983-0903
CY2024Q1 dei Security12b Title
Security12bTitle
Common Units of Beneficial Interest
CY2024Q1 dei Trading Symbol
TradingSymbol
DBA
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NYSEArca
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31850000
CY2024Q1 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
322176156
CY2023Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
342956644
CY2024Q1 us-gaap Receivables From Clearing Organizations
ReceivablesFromClearingOrganizations
3605931
CY2023Q4 us-gaap Cash
Cash
4721066
CY2023Q4 dba Receivable From Fund Shares Sold
ReceivableFromFundSharesSold
2074305
CY2024Q1 us-gaap Dividends Receivable
DividendsReceivable
1324591
CY2023Q4 us-gaap Dividends Receivable
DividendsReceivable
1403400
CY2024Q1 us-gaap Assets
Assets
789244216
CY2023Q4 us-gaap Assets
Assets
718970873
CY2023Q4 dba Payable To Clearing Organizations
PayableToClearingOrganizations
10687335
CY2023Q4 us-gaap Distribution Payable
DistributionPayable
336157
CY2023Q4 dba Payable For Fund Shares Reacquired
PayableForFundSharesReacquired
3157545
CY2024Q1 us-gaap Management Fee Payable
ManagementFeePayable
505146
CY2023Q4 us-gaap Management Fee Payable
ManagementFeePayable
520593
CY2024Q1 us-gaap Commissions Payable To Broker Dealers And Clearing Organizations
CommissionsPayableToBrokerDealersAndClearingOrganizations
4918
CY2023Q4 us-gaap Commissions Payable To Broker Dealers And Clearing Organizations
CommissionsPayableToBrokerDealersAndClearingOrganizations
2673
CY2024Q1 us-gaap Liabilities
Liabilities
510064
CY2023Q4 us-gaap Liabilities
Liabilities
14704303
CY2024Q1 us-gaap General Partners Capital Account
GeneralPartnersCapitalAccount
990
CY2023Q4 us-gaap General Partners Capital Account
GeneralPartnersCapitalAccount
830
CY2024Q1 us-gaap Limited Partners Capital Account
LimitedPartnersCapitalAccount
788733162
CY2023Q4 us-gaap Limited Partners Capital Account
LimitedPartnersCapitalAccount
704265740
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
788734152
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
704266570
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
789244216
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
718970873
CY2024Q1 us-gaap General Partners Capital Account Units Outstanding
GeneralPartnersCapitalAccountUnitsOutstanding
40
CY2023Q4 us-gaap General Partners Capital Account Units Outstanding
GeneralPartnersCapitalAccountUnitsOutstanding
40
CY2024Q1 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
31850000
CY2023Q4 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
33950000
CY2024Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
24.76
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
20.74
CY2024Q1 dba Market Value Per Share
MarketValuePerShare
24.75
CY2023Q4 dba Market Value Per Share
MarketValuePerShare
20.73
CY2024Q1 us-gaap Investment Interest Rate
InvestmentInterestRate
0.05255
CY2024Q1 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-05-30
CY2024Q1 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.3771
CY2024Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
297415062
CY2024Q1 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
300000000
CY2024Q1 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0524
CY2024Q1 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-06-06
CY2024Q1 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.0314
CY2024Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
24761094
CY2024Q1 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
25000000
CY2024Q1 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
322134780
CY2024Q1 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.4085
CY2024Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
322176156
CY2024Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
91562981
CY2024Q1 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
91562981
CY2024Q1 dba Investments In And Advances To Affiliates At Cost
InvestmentsInAndAdvancesToAffiliatesAtCost
119520055
CY2024Q1 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.1516
CY2024Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
119581885
CY2024Q1 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
1133800
CY2024Q1 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0525
CY2024Q1 dba Investments In And Advances To Affiliates At Cost
InvestmentsInAndAdvancesToAffiliatesAtCost
342555653
CY2024Q1 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.4343
CY2024Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
342555653
CY2024Q1 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
342555653
CY2024Q1 dba Investments In And Advances To Affiliates At Cost
InvestmentsInAndAdvancesToAffiliatesAtCost
462075708
CY2024Q1 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.5859
CY2024Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
462137538
CY2024Q1 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
784210488
CY2024Q1 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.9944
CY2024Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
784313694
CY2024Q1 us-gaap Good Faith And Margin Deposits With Broker Dealers
GoodFaithAndMarginDepositsWithBrokerDealers
148695000
CY2024Q1 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
3377
CY2024Q1 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
78430825
CY2024Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-7925163
CY2024Q1 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-7925163
CY2024Q1 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1331
CY2024Q1 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
78944938
CY2024Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-5086905
CY2024Q1 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-5086905
CY2024Q1 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1330
CY2024Q1 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
38287375
CY2024Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-5736089
CY2024Q1 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-5736089
CY2024Q1 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1268
CY2024Q1 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
36756150
CY2024Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-9157459
CY2024Q1 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-9157459
CY2024Q1 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
238
CY2024Q1 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
29595300
CY2024Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-1097089
CY2024Q1 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-1097089
CY2024Q1 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1466
CY2024Q1 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
59490280
CY2024Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1471
CY2024Q1 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
1471
CY2024Q1 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1205
CY2024Q1 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
86880500
CY2024Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-1564970
CY2024Q1 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-1564970
CY2024Q1 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
2000
CY2024Q1 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
195320000
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
710772102
CY2024Q1 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1204
CY2024Q1 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
85265775
CY2024Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
891821
CY2024Q1 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
891821
CY2024Q1 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
487
CY2024Q1 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
22251030
CY2024Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
644628
CY2024Q1 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
644628
CY2024Q1 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
3108
CY2024Q1 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
77103264
CY2024Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-2659538
CY2024Q1 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-2659538
CY2024Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
59873688
CY2024Q1 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
59873688
CY2023Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0525
CY2023Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-03-07
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.0352
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
24765221
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
25000000
CY2023Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0524
CY2023Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-05-30
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.4171
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
293737965
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
300000000
CY2023Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0519
CY2023Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-06-06
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.0347
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
24453458
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
25000000
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
342604310
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.487
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
342956644
CY2023Q4 dba Investments In And Advances To Affiliates At Cost
InvestmentsInAndAdvancesToAffiliatesAtCost
119520055
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.1699
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
119734949
CY2023Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
1133800
CY2023Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0529
CY2023Q4 dba Investments In And Advances To Affiliates At Cost
InvestmentsInAndAdvancesToAffiliatesAtCost
248080509
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.3523
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
248080509
CY2023Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
248080509
CY2023Q4 dba Investments In And Advances To Affiliates At Cost
InvestmentsInAndAdvancesToAffiliatesAtCost
367600564
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.5222
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
367815458
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
710204874
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
1.0092
CY2023Q4 us-gaap Good Faith And Margin Deposits With Broker Dealers
GoodFaithAndMarginDepositsWithBrokerDealers
146865000
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
3564
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
88565400
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-2696057
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-2696057
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1405
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
87513938
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-1282131
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-1282131
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1401
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
45234788
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-1339435
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-1339435
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1338
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
43217400
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-5650533
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-5650533
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
258
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
28779900
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1161102
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
1161102
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
2023
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
55005370
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-5957186
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-5957186
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1265
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
85261000
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-6678115
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-6678115
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
2052
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
86101920
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
5543802
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
5543802
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1250
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
88265625
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
8413856
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
8413856
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
519
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
21019500
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
325083
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
325083
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
3282
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
75023894
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-9139633
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-9139633
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-17299247
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-17299247
CY2024Q1 us-gaap Interest Income Operating
InterestIncomeOperating
4557104
CY2023Q1 us-gaap Interest Income Operating
InterestIncomeOperating
4934807
CY2024Q1 us-gaap Dividend Income Operating
DividendIncomeOperating
4889242
CY2023Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
188125376
CY2023Q1 dba Stockholders Equity Period Increase Decrease Due To Share Transactions
StockholdersEquityPeriodIncreaseDecreaseDueToShareTransactions
-171908428
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
8519867
CY2023Q1 us-gaap Dividend Income Operating
DividendIncomeOperating
5689615
CY2024Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
9446346
CY2023Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
10624422
CY2024Q1 us-gaap Investment Company General Partner Advisory Service
InvestmentCompanyGeneralPartnerAdvisoryService
1513790
CY2023Q1 us-gaap Investment Company General Partner Advisory Service
InvestmentCompanyGeneralPartnerAdvisoryService
2047635
CY2024Q1 us-gaap Floor Brokerage Exchange And Clearance Fees
FloorBrokerageExchangeAndClearanceFees
77636
CY2023Q1 us-gaap Floor Brokerage Exchange And Clearance Fees
FloorBrokerageExchangeAndClearanceFees
128727
CY2024Q1 us-gaap Interest Expense
InterestExpense
40115
CY2023Q1 us-gaap Interest Expense
InterestExpense
41340
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
1631541
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
2217702
CY2024Q1 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
87043
CY2023Q1 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
113147
CY2024Q1 dba Operating Expenses Net
OperatingExpensesNet
1544498
CY2023Q1 dba Operating Expenses Net
OperatingExpensesNet
2104555
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
7901848
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
8519867
CY2023Q1 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-62
CY2024Q1 us-gaap Gain Loss On Sale Of Commodity Contracts
GainLossOnSaleOfCommodityContracts
44402988
CY2023Q1 us-gaap Gain Loss On Sale Of Commodity Contracts
GainLossOnSaleOfCommodityContracts
84577
CY2024Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
44402988
CY2023Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
84515
CY2024Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-310958
CY2023Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
65455
CY2024Q1 dba Unrealized Gain Loss On Affiliated Investments
UnrealizedGainLossOnAffiliatedInvestments
-153064
CY2023Q1 dba Unrealized Gain Loss On Affiliated Investments
UnrealizedGainLossOnAffiliatedInvestments
194029
CY2024Q1 us-gaap Unrealized Gain Loss On Commodity Contracts
UnrealizedGainLossOnCommodityContracts
77172935
CY2023Q1 us-gaap Unrealized Gain Loss On Commodity Contracts
UnrealizedGainLossOnCommodityContracts
-830827
CY2024Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
76708913
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-571343
CY2024Q1 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
121111901
CY2023Q1 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
-486828
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
129013749
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
8033039
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
704266570
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10776953
CY2024Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
55323120
CY2024Q1 dba Stockholders Equity Period Increase Decrease Due To Share Transactions
StockholdersEquityPeriodIncreaseDecreaseDueToShareTransactions
-44546167
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
7901848
CY2024Q1 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
44402988
CY2024Q1 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
76708913
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
129013749
CY2024Q1 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
84467582
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
788734152
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1072706930
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
16216948
CY2023Q1 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
84515
CY2023Q1 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
-571343
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
8033039
CY2023Q1 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-163875389
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
908831541
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
129013749
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
8033039
CY2023Q1 us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
370495500
CY2024Q1 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
25000000
CY2023Q1 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
574999938
CY2024Q1 dba Cost Of Affiliated Investments Purchased
CostOfAffiliatedInvestmentsPurchased
204940989
CY2023Q1 dba Cost Of Affiliated Investments Purchased
CostOfAffiliatedInvestmentsPurchased
650762486
CY2024Q1 dba Proceeds From Affiliated Investments Sold
ProceedsFromAffiliatedInvestmentsSold
110465845
CY2023Q1 dba Proceeds From Affiliated Investments Sold
ProceedsFromAffiliatedInvestmentsSold
634447158
CY2024Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
-4530470
CY2023Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
-4909248
CY2023Q1 dba Realized Gain Loss On Marketable Securities And Affiliated Investments
RealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
-62
CY2024Q1 dba Unrealized Gain Loss On Marketable Securities And Affiliated Investments
UnrealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
-464022
CY2023Q1 dba Unrealized Gain Loss On Marketable Securities And Affiliated Investments
UnrealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
259484
CY2024Q1 dba Increase Decrease In Variation Margin
IncreaseDecreaseInVariationMargin
14293266
CY2023Q1 dba Increase Decrease In Variation Margin
IncreaseDecreaseInVariationMargin
6980431
CY2024Q1 us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
-78809
CY2023Q1 us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
-79250
CY2024Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-15447
CY2023Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-199264
CY2024Q1 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
2245
CY2023Q1 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
2182
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
41244498
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
183955216
CY2024Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
336157
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12851258
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
16216948
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
58480665
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
200172164
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-45965564
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-183955216
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-4721066
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4721066
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
40115
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
41340
CY2006Q3 dba Number Of Series Of Trusts
NumberOfSeriesOfTrusts
5
CY2015Q1 us-gaap General Partners Capital Account Units Outstanding
GeneralPartnersCapitalAccountUnitsOutstanding
40
CY2024Q1 dba Treasury Obligation Measurement Maximum Maturity Period
TreasuryObligationMeasurementMaximumMaturityPeriod
P12M
CY2024Q1 dba Minimum Number Of Creation Units Of Shares That Can Be Purchased
MinimumNumberOfCreationUnitsOfSharesThatCanBePurchased
1
CY2024Q1 dba Number Of Shares Issued Per Creation Unit
NumberOfSharesIssuedPerCreationUnit
50000
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">B.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accounting Estimates</span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates by a significant amount. In addition, the Fund monitors for material events or transactions that may occur or become known after the period-end date and before the date the financial statements are issued.</span></p>
CY2024Q1 us-gaap Distributed Earnings
DistributedEarnings
0
CY2023Q1 us-gaap Distributed Earnings
DistributedEarnings
0
CY2024Q1 us-gaap Other Nonrecurring Expense
OtherNonrecurringExpense
0
CY2023Q1 us-gaap Other Nonrecurring Expense
OtherNonrecurringExpense
0
CY2024Q1 dba Average Charges Paid To Broker Per Round Turn Trade Maximum
AverageChargesPaidToBrokerPerRoundTurnTradeMaximum
7
CY2023Q1 dba Average Charges Paid To Broker Per Round Turn Trade Maximum
AverageChargesPaidToBrokerPerRoundTurnTradeMaximum
7
CY2024Q1 dba Management Fee Per Annum Of Daily Net Assets
ManagementFeePerAnnumOfDailyNetAssets
0.0085
CY2024Q1 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
87043
CY2023Q1 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
113147
CY2024Q1 us-gaap Due To And From Broker Dealers And Clearing Organizations Disclosure
DueToAndFromBrokerDealersAndClearingOrganizationsDisclosure
<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 5 – Deposits with Commodity Broker and Custodian</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Fund defines cash as cash held by the Custodian. There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> cash equivalents held by the Fund as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">March 31, 2024 and December 31, 2023. The Fund considers investments in money market funds to be investments in securities and, accordingly, includes them in its Schedule of Investments.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Fund may deposit cash, United States Treasury Obligations, T-Bill ETFs and money market mutual funds with the Commodity Broker as margin, to the extent permissible under CFTC rules. The combination of the Fund’s deposits with its Commodity Broker of cash and United States Treasury Obligations and the unrealized profit or loss on open futures contracts represents the Fund’s overall equity in its broker trading account. To meet the Fund’s maintenance margin requirements, the Fund holds United States Treasury Obligations with the Commodity Broker. The Fund transfers cash to the Commodity Broker to satisfy variation margin requirements. The Fund earns interest on any excess cash deposited with the Commodity Broker and incurs interest expense on any deficit balance with the Commodity Broker.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The brokerage agreement with the Commodity Broker provides for the net settlement of all financial instruments covered by the agreement in the event of default or termination of any one contract. The Managing Owner will utilize any excess cash held at the Commodity Broker to offset any realized losses incurred in the commodity futures contracts, if available. To the extent that any excess cash held at the Commodity Broker is not adequate to cover any realized losses, a portion of the United States Treasury Obligations and T-Bill ETFs, if any, on deposit with the Commodity Broker will be sold to make additional cash available. For financial reporting purposes, the Fund offsets financial assets and financial liabilities that are subject to legally enforceable netting arrangements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Fund’s remaining cash, United States Treasury Obligations, T-Bill ETFs and money market mutual fund holdings are on deposit with the Custodian. The Fund is permitted to temporarily carry a negative or overdrawn balance in its account with the Custodian. The Fund incurs interest expense on any overdraft balance with the Custodian. Such balances, if any at period-end, are shown on the Statements of Financial Condition under the payable caption </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Due to custodian</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Because the Fund’s assets are maintained with the Commodity Broker and Custodian, the distress, impairment or failure of the Commodity Broker or Custodian could result in the loss of or delay in access to Fund assets.</span></p>
CY2024Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2024Q1 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
322176156
CY2024Q1 dba Financial Instruments Owned Exchange Traded Fund
FinancialInstrumentsOwnedExchangeTradedFund
119581885
CY2024Q1 dba Financial Instruments Owned Money Market Mutual Fund At Fair Value
FinancialInstrumentsOwnedMoneyMarketMutualFundAtFairValue
342555653
CY2024Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
784313694
CY2024Q1 us-gaap Investment Owned Unrecognized Unrealized Appreciation
InvestmentOwnedUnrecognizedUnrealizedAppreciation
93100901
CY2024Q1 us-gaap Investment Owned Unrecognized Unrealized Depreciation
InvestmentOwnedUnrecognizedUnrealizedDepreciation
33227213
CY2024Q1 us-gaap Investment Owned Unrecognized Unrealized Appreciation Depreciation Net
InvestmentOwnedUnrecognizedUnrealizedAppreciationDepreciationNet
59873688
CY2024Q1 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
844187382
CY2023Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
342956644
CY2023Q4 dba Financial Instruments Owned Exchange Traded Fund
FinancialInstrumentsOwnedExchangeTradedFund
119734949
CY2023Q4 dba Financial Instruments Owned Money Market Mutual Fund At Fair Value
FinancialInstrumentsOwnedMoneyMarketMutualFundAtFairValue
248080509
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
710772102
CY2023Q4 us-gaap Investment Owned Unrecognized Unrealized Appreciation
InvestmentOwnedUnrecognizedUnrealizedAppreciation
15443843
CY2023Q4 us-gaap Investment Owned Unrecognized Unrealized Depreciation
InvestmentOwnedUnrecognizedUnrealizedDepreciation
32743090
CY2023Q4 us-gaap Investment Owned Unrecognized Unrealized Appreciation Depreciation Net
InvestmentOwnedUnrecognizedUnrealizedAppreciationDepreciationNet
-17299247
CY2023Q4 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
693472855
CY2024Q1 dba Minimum Number Of Creation Units Of Shares That Can Be Purchased
MinimumNumberOfCreationUnitsOfSharesThatCanBePurchased
1
CY2024Q1 dba Number Of Shares Issued Per Creation Unit
NumberOfSharesIssuedPerCreationUnit
50000
CY2024Q1 dba Minimum Number Of Creation Units Of Shares That Can Be Redeemed
MinimumNumberOfCreationUnitsOfSharesThatCanBeRedeemed
1
CY2024Q1 dba Number Of Shares Redeemable Per Creation Unit
NumberOfSharesRedeemablePerCreationUnit
50000
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
20.74
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
20.16
CY2024Q1 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
3.78
CY2023Q1 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
0.09
CY2024Q1 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.24
CY2023Q1 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.17
CY2024Q1 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
4.02
CY2023Q1 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
0.26
CY2024Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
24.76
CY2023Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
20.42
CY2023Q4 dba Market Value Per Share
MarketValuePerShare
20.73
CY2022Q4 dba Market Value Per Share
MarketValuePerShare
20.15
CY2024Q1 dba Market Value Per Share
MarketValuePerShare
24.75
CY2023Q1 dba Market Value Per Share
MarketValuePerShare
20.43
CY2024Q1 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0444
CY2023Q1 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0355
CY2024Q1 us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0087
CY2023Q1 us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0088
CY2024Q1 dba Average Net Assets To Expenses Prior To Waivers
AverageNetAssetsToExpensesPriorToWaivers
0.0092
CY2023Q1 dba Average Net Assets To Expenses Prior To Waivers
AverageNetAssetsToExpensesPriorToWaivers
0.0092
CY2024Q1 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.1938
CY2023Q1 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.0129
CY2024Q1 dba Return At Market Value
ReturnAtMarketValue
0.1939
CY2023Q1 dba Return At Market Value
ReturnAtMarketValue
0.0139
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 dba Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false
CY2024Q1 dba Non Rule10 B51 Arr Modified Flag
NonRule10B51ArrModifiedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-054963-index-headers.html Edgar Link pending
0000950170-24-054963-index.html Edgar Link pending
0000950170-24-054963.txt Edgar Link pending
0000950170-24-054963-xbrl.zip Edgar Link pending
dba-20240331.htm Edgar Link pending
dba-20240331.xsd Edgar Link pending
dba-ex31_1.htm Edgar Link pending
dba-ex31_2.htm Edgar Link pending
dba-ex32_1.htm Edgar Link pending
dba-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img238547851_0.jpg Edgar Link pending
img238547851_1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
dba-20240331_htm.xml Edgar Link completed
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending